• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: a retrospective cohort analysis.医保报销归因于住院患者中与导尿管相关的尿路感染:一项回顾性队列分析。
Med Care. 2014 Jun;52(6):469-78. doi: 10.1097/MLR.0000000000000106.
2
Not paying for catheter-associated urinary tract infections: more difficult than it seems?导管相关尿路感染无需付费:比看上去更难实现?
Med Care. 2014 Jun;52(6):479-81. doi: 10.1097/MLR.0000000000000139.
3
Centers for medicare and medicaid services hospital-acquired conditions policy for central line-associated bloodstream infection (CLABSI) and catheter-associated urinary tract infection (CAUTI) shows minimal impact on hospital reimbursement.医疗保险和医疗补助服务中心针对中心静脉导管相关血流感染(CLABSI)和导尿管相关尿路感染(CAUTI)的医院获得性感染政策对医院报销的影响微乎其微。
Infect Control Hosp Epidemiol. 2018 Aug;39(8):897-901. doi: 10.1017/ice.2018.137. Epub 2018 Jun 28.
4
The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review.美国与导管相关的尿路感染的归因成本:系统评价。
Am J Infect Control. 2018 Jul;46(7):751-757. doi: 10.1016/j.ajic.2018.01.015. Epub 2018 Feb 22.
5
Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections.导管相关尿路感染(CAUTI)和非 CAUTI 医院获得性尿路感染:相对负担、成本、结局以及相关的医院获得性菌血症和真菌血症感染。
Infect Control Hosp Epidemiol. 2024 Jul;45(7):864-871. doi: 10.1017/ice.2024.26. Epub 2024 Feb 20.
6
The Hospital-Acquired Conditions (HAC) reduction program: using cranberry treatment to reduce catheter-associated urinary tract infections and avoid Medicare payment reduction penalties.医院获得性疾病(HAC)减少计划:采用蔓越莓治疗以减少导尿管相关的尿路感染并避免医疗保险支付减少处罚。
J Med Econ. 2018 Jan;21(1):97-106. doi: 10.1080/13696998.2017.1396993. Epub 2017 Nov 14.
7
Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.医院获得性、导管相关尿路感染未予支付的影响:全州范围分析。
Ann Intern Med. 2012 Sep 4;157(5):305-12. doi: 10.7326/0003-4819-157-5-201209040-00003.
8
Initial impact of Medicare's nonpayment policy on catheter-associated urinary tract infections by hospital characteristics.医疗保险不支付政策对不同医院特征的导尿管相关尿路感染的初步影响。
Health Policy. 2014 Apr;115(2-3):165-71. doi: 10.1016/j.healthpol.2013.11.013. Epub 2013 Dec 5.
9
Patient-level cost analysis of intensive care unit-acquired infections: a prospective cohort study.重症监护病房获得性感染的患者层面成本分析:一项前瞻性队列研究。
J Hosp Infect. 2025 May;159:106-114. doi: 10.1016/j.jhin.2024.07.002. Epub 2024 Jul 18.
10
Eliminating catheter-associated urinary tract infections in the intensive care unit: is it an attainable goal?消除重症监护病房中的导管相关尿路感染:这是一个可实现的目标吗?
Am J Surg. 2014 Dec;208(6):1065-70; discussion 1069-70. doi: 10.1016/j.amjsurg.2014.08.013. Epub 2014 Sep 28.

引用本文的文献

1
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection.复杂性尿路感染流行病学的系统文献综述
Infect Dis Ther. 2025 Apr 24. doi: 10.1007/s40121-025-01149-8.
2
Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework.使用类比成本框架衡量医院获得性感染的直接医疗成本。
Pharmacoeconomics. 2024 Oct;42(10):1127-1144. doi: 10.1007/s40273-024-01400-z. Epub 2024 Jul 5.
3
Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.与美国医院中心静脉相关血流感染和医院获得性菌血症及真菌血症相关的特征、成本和结局。
Infect Control Hosp Epidemiol. 2023 Dec;44(12):1920-1926. doi: 10.1017/ice.2023.132. Epub 2023 Jul 10.
4
Diagnostic Stewardship in the Pediatric Intensive Care Unit.儿科重症监护病房的诊断管理。
Infect Dis Clin North Am. 2022 Mar;36(1):203-218. doi: 10.1016/j.idc.2021.11.003.
5
Administration of indwelling urinary catheters in four Australian Hospitals: cost-effectiveness analysis of a multifaceted nurse-led intervention.澳大利亚四家医院留置导尿管的管理:多方面护士主导干预的成本效益分析。
BMC Health Serv Res. 2021 Aug 31;21(1):897. doi: 10.1186/s12913-021-06871-w.
6
Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis.了解医疗保健相关感染的经济影响:成本视角分析
J Infus Nurs. 2019 Mar/Apr;42(2):61-69. doi: 10.1097/NAN.0000000000000313.
7
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.美国耐碳青霉烯类肠杆菌科细菌(CRE)的潜在经济负担。
Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16. doi: 10.1016/j.cmi.2016.09.003. Epub 2016 Sep 15.
8
Prevention of Nosocomial Infection in the Neurosciences Intensive Care Unit: Remember the Basics.神经科学重症监护病房医院感染的预防:牢记基本原则。
Neurocrit Care. 2016 Oct;25(2):167-9. doi: 10.1007/s12028-016-0314-2.
9
The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections.医院获得性中心静脉导管相关血流感染患者再次入院的可能性
Infect Control Hosp Epidemiol. 2015 Aug;36(8):886-92. doi: 10.1017/ice.2015.115. Epub 2015 May 20.
10
The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.通过实施多方面的感染控制和抗菌药物管理计划,联邦政府在预防艰难梭菌感染方面投资的成本效益。
Infect Control Hosp Epidemiol. 2015 Jun;36(6):681-7. doi: 10.1017/ice.2015.43. Epub 2015 Mar 18.

本文引用的文献

1
Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.医院获得性、导管相关尿路感染未予支付的影响:全州范围分析。
Ann Intern Med. 2012 Sep 4;157(5):305-12. doi: 10.7326/0003-4819-157-5-201209040-00003.
2
Health characteristics of Medicare traditional fee-for-service and Medicare Advantage enrollees: 1999-2004 National Health and Nutrition Examination Survey linked to 2007 Medicare data.医疗保险传统按服务项目付费和医疗保险优势计划参保人的健康特征:1999 - 2004年与2007年医疗保险数据相链接的国家健康和营养检查调查
Natl Health Stat Report. 2012 May 3(53):1-12.
3
Adoption of policies to prevent catheter-associated urinary tract infections in United States intensive care units.美国重症监护病房预防导尿管相关尿路感染的政策采纳情况。
Am J Infect Control. 2012 Oct;40(8):705-10. doi: 10.1016/j.ajic.2011.09.020. Epub 2012 Feb 7.
4
National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module.国家医疗安全网络(NHSN)报告,2010年数据摘要,器械相关模块
Am J Infect Control. 2011 Dec;39(10):798-816. doi: 10.1016/j.ajic.2011.10.001.
5
Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.估算合理可预防的医疗保健相关感染的比例,以及相关的死亡率和成本。
Infect Control Hosp Epidemiol. 2011 Feb;32(2):101-14. doi: 10.1086/657912.
6
Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies.导管相关性尿路感染与危重症患者死亡率和住院时间的关系:系统评价和观察性研究的荟萃分析。
Crit Care Med. 2011 May;39(5):1167-73. doi: 10.1097/CCM.0b013e31820a8581.
7
A combined comorbidity score predicted mortality in elderly patients better than existing scores.联合合并症评分预测老年患者死亡率优于现有评分。
J Clin Epidemiol. 2011 Jul;64(7):749-59. doi: 10.1016/j.jclinepi.2010.10.004. Epub 2011 Jan 5.
8
Epidural abscess T5T8 due to methicillin-resistent staphylococcus aureus in an immunocompetent patient.免疫功能正常患者因耐甲氧西林金黄色葡萄球菌导致胸5至胸8硬膜外脓肿
Acta Orthop Belg. 2010 Oct;76(5):706-8.
9
Definite infective endocarditis: clinical and microbiological features of 155 episodes in one Japanese university hospital.明确感染性心内膜炎:一家日本大学医院 155 例的临床和微生物学特征。
J Formos Med Assoc. 2010 Nov;109(11):788-99. doi: 10.1016/S0929-6646(10)60124-6.
10
[From case to case: staying on the safe side].具体情况具体分析:确保安全
Pflege Z. 2010 Nov;63(11):692-3.

医保报销归因于住院患者中与导尿管相关的尿路感染:一项回顾性队列分析。

Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: a retrospective cohort analysis.

机构信息

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.

出版信息

Med Care. 2014 Jun;52(6):469-78. doi: 10.1097/MLR.0000000000000106.

DOI:10.1097/MLR.0000000000000106
PMID:24699236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11413967/
Abstract

BACKGROUND

Most catheter-associated urinary tract infections (CAUTIs) are considered preventable and thus a potential target for health care quality improvement and cost savings.

OBJECTIVES

We sought to estimate excess Medicare reimbursement, length of stay, and inpatient death associated with CAUTI among hospitalized beneficiaries.

RESEARCH DESIGN

Using a retrospective cohort design with linked Medicare inpatient claims and National Healthcare Safety Network data from 2009, we compared Medicare reimbursement between Medicare beneficiaries with and without CAUTIs.

SUBJECTS

Fee-for-service Medicare beneficiaries aged 65 years or older with continuous coverage of parts A (hospital insurance) and B (supplementary medical insurance).

RESULTS

We found that beneficiaries with CAUTI had higher median Medicare reimbursement [intensive care unit (ICU): $8548, non-ICU: $1479) and length of stay (ICU: 8.1 d, non-ICU: 3.6 d) compared with those without CAUTI controlling for potential confounding factors. Odds of inpatient death were higher among beneficiaries with versus without CAUTI only among those with an ICU stay (ICU: odds ratio 1.37).

CONCLUSIONS

Beneficiaries with CAUTI had increased Medicare reimbursement and length of stay compared with those without CAUTI after adjusting for potential confounders.

摘要

背景

大多数与导管相关的尿路感染(CAUTI)被认为是可以预防的,因此是医疗保健质量改进和节省成本的潜在目标。

目的

我们旨在估计与住院患者的 CAUTI 相关的医疗保险过度报销、住院时间和住院死亡。

研究设计

使用回顾性队列设计,结合 2009 年医疗保险住院索赔和国家医疗保健安全网络数据,我们比较了有和没有 CAUTI 的医疗保险受益人的医疗保险报销情况。

研究对象

年龄在 65 岁或以上、有 A 部分(医院保险)和 B 部分(补充医疗保险)连续保险的医疗保险按服务收费受益人的。

结果

我们发现,在控制了潜在混杂因素后,与没有 CAUTI 的患者相比,有 CAUTI 的患者的医疗保险报销中位数更高[重症监护病房(ICU):8548 美元,非 ICU:1479 美元]和住院时间(ICU:8.1 天,非 ICU:3.6 天)。只有在 ICU 住院的患者中,与没有 CAUTI 的患者相比,CAUTI 患者的住院期间死亡的可能性更高(ICU:比值比 1.37)。

结论

在调整了潜在混杂因素后,与没有 CAUTI 的患者相比,有 CAUTI 的患者的医疗保险报销和住院时间增加。